| RNP | XLRE | RNP / XLRE | |
| Gain YTD | 2.799 | 1.922 | 146% |
| Net Assets | 998M | 7.48B | 13% |
| Total Expense Ratio | 1.31 | 0.08 | 1,638% |
| Turnover | 40.00 | 5.00 | 800% |
| Yield | 5.70 | 3.40 | 168% |
| Fund Existence | 22 years | 10 years | - |
| RNP | XLRE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | N/A |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 81% |
| Advances ODDS (%) | 9 days ago 87% | 20 days ago 87% |
| Declines ODDS (%) | 3 days ago 83% | 7 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 90% | N/A |
| Aroon ODDS (%) | 2 days ago 75% | N/A |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LCLG | 60.63 | 0.05 | +0.08% |
| Logan Capital Broad Innovative Gr ETF | |||
| LAPR | 25.16 | N/A | N/A |
| Innovator Premium Inc 15 Bffr ETF - Aprl | |||
| IPAC | 72.50 | -0.15 | -0.21% |
| iShares Core MSCI Pacific ETF | |||
| THNR | 25.13 | -0.08 | -0.33% |
| Amplify Weight Loss Drug & Treatment ETF | |||
| USOI | 49.08 | -0.78 | -1.57% |
| UBS ETRACS Crude Oil Shares Cov Cll ETN | |||
A.I.dvisor indicates that over the last year, XLRE has been closely correlated with EQR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLRE jumps, then EQR could also see price increases.
| Ticker / NAME | Correlation To XLRE | 1D Price Change % | ||
|---|---|---|---|---|
| XLRE | 100% | -0.78% | ||
| EQR - XLRE | 85% Closely correlated | -0.41% | ||
| UDR - XLRE | 84% Closely correlated | +0.23% | ||
| AVB - XLRE | 83% Closely correlated | -0.25% | ||
| REG - XLRE | 82% Closely correlated | -0.58% | ||
| CPT - XLRE | 81% Closely correlated | +0.13% | ||
More | ||||